Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 4.87165 | 74 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 4.94037 | 75 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 5.11023 | 76 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 5.39411 | 77 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 4.80995 | 74 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 4.10633 | 67 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 4.8537 | 75 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 4.82927 | 74 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 4.78364 | 74 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 5.26746 | 77 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 4.9064 | 75 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 4.83417 | 74 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 4.76422 | 74 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 4.78251 | 74 |